Scholarlink

<p>Interventions aimed at the diagnosis of viral hepatitis in migrants from countries with high prevalence rates are essential to achieve the elimination of viral hepatitis. The objective was to perform a cost-effectiveness analysis of a community screening strategy for hepatitis B and C virus (HBV and HCV) infections versus no intervention in migrant populations in Catalonia. HBV and HCV decision trees for the community strategy (from community screening to simplified access to care and treatment) and Markov models to simulate hepatitis B and C disease progression were developed. Sensitivity analyses were performed with the parameters with the highest uncertainty. Among the 2291 people screened, 74 and 21 cases of HBV and HCV infection were diagnosed, which avoided 79% and 62% of liver complications related to HBV and HCV, respectively. Community HCV screening showed an incremental cost of €13,999/patient versus no intervention and 2.98 quality-adjusted life years (QALYs) per patient, resulting in an incremental cost‒utility ratio of €4692/QALY gained. The HBV strategy was dominant. The distribution of HCV patients across different fibrosis stages had a greater impact on sensitivity analyses. Implementing a community screening strategy, which also increased awareness of HBV and HCV infections and treatment in migrant populations, is cost-effective.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cost-effectiveness of community interventions to promote awareness, testing and treatment of hepatitis B and C in migrant populations in Catalonia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月20日

查看全文
  • Elisa Martró,
  • Raquel Domínguez-Hernández,
  • Venus Forero,
  • Jordi Gómez i Prat,
  • Anna Not,
  • Sandra Manzanares-Laya,
  • Marcos Montoro,
  • Manuel Gómez-Barrera,
  • Maria Buti,
  • Jordi Casabona,
  • Xavier Majó,
  • Joan Colom

摘要

Interventions aimed at the diagnosis of viral hepatitis in migrants from countries with high prevalence rates are essential to achieve the elimination of viral hepatitis. The objective was to perform a cost-effectiveness analysis of a community screening strategy for hepatitis B and C virus (HBV and HCV) infections versus no intervention in migrant populations in Catalonia. HBV and HCV decision trees for the community strategy (from community screening to simplified access to care and treatment) and Markov models to simulate hepatitis B and C disease progression were developed. Sensitivity analyses were performed with the parameters with the highest uncertainty. Among the 2291 people screened, 74 and 21 cases of HBV and HCV infection were diagnosed, which avoided 79% and 62% of liver complications related to HBV and HCV, respectively. Community HCV screening showed an incremental cost of €13,999/patient versus no intervention and 2.98 quality-adjusted life years (QALYs) per patient, resulting in an incremental cost‒utility ratio of €4692/QALY gained. The HBV strategy was dominant. The distribution of HCV patients across different fibrosis stages had a greater impact on sensitivity analyses. Implementing a community screening strategy, which also increased awareness of HBV and HCV infections and treatment in migrant populations, is cost-effective.